| Trial ID: | L3928 |
| Source ID: | NCT01399346
|
| Associated Drug: |
Insulin Aspart
|
| Title: |
Investigation of the Impact of Different Application Volumes of Insulin Aspart in Subjects With Type 1 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 1 Diabetes
|
| Interventions: |
DRUG: Insulin aspart|DRUG: Insulin aspart
|
| Outcome Measures: |
Primary: tmax(ins), time to maximum observed serum insulin aspart concentration, 8 hours | Secondary: t10%max(ins), time to reach 10% of maximum observed serum insulin aspart concentration, 8 hours
|
| Sponsor/Collaborators: |
Sponsor: Medical University of Graz | Collaborators: European Commission
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
12
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2011-04
|
| Completion Date: |
2011-06
|
| Results First Posted: |
|
| Last Update Posted: |
2012-04-20
|
| Locations: |
Medical University of Graz, Graz, 8036, Austria
|
| URL: |
https://clinicaltrials.gov/show/NCT01399346
|
